Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Blank

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Gynecologic Oncology|October 4, 2005
Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortiumD Yi-Shin Kuo, Patrick Timmins, Stephanie V Blank, et al.
Gynecologic Oncology|September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessmentStephanie V Blank, Paul Christos, John P Curtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancerCarol Aghajanian, Stephanie V Blank, Barbara A Goff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 17, 2020
The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of lifeFrances Reid, Neerja Bhatla, Amit M Oza, et al.
Gynecologic Oncology|October 18, 2025
Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistributionSharonne Holtzman, Evan Myers, Laura J Havrilesky, et al.
Cancer Immunology, Immunotherapy : CII|March 13, 2021
Tumor immune microenvironment in brain metastases from gynecologic malignanciesCorey M Gill, Megan R D'Andrea, Shannon Tomita, et al.
Gynecologic Oncology|February 22, 2025
Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individualsAngela C Nolin, Sage L Atkins, Evan R Myers, et al.
Gynecologic Oncology|December 10, 2016
Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancerFernanda Musa, Bhavana Pothuri, Stephanie V Blank, et al.
Gynecologic Oncology|September 18, 2014
A qualitative study of ovarian cancer survivors' perceptions of endpoints and goals of careMelissa K Frey, Sarah R Philips, Julia Jeffries, et al.
Endocrinology|September 17, 2013
Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancerSavvas C Pavlides, Kuang-Tzu Huang, Dylan A Reid, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|October 4, 2005
Phase II trial of thalidomide for advanced and recurrent gynecologic sarcoma: a brief communication from the New York Phase II consortiumD Yi-Shin Kuo, Patrick Timmins, Stephanie V Blank, et al.
Gynecologic Oncology|September 15, 2010
Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessmentStephanie V Blank, Paul Christos, John P Curtin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancerCarol Aghajanian, Stephanie V Blank, Barbara A Goff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 17, 2020
The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of lifeFrances Reid, Neerja Bhatla, Amit M Oza, et al.
Gynecologic Oncology|October 18, 2025
Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistributionSharonne Holtzman, Evan Myers, Laura J Havrilesky, et al.
Cancer Immunology, Immunotherapy : CII|March 13, 2021
Tumor immune microenvironment in brain metastases from gynecologic malignanciesCorey M Gill, Megan R D'Andrea, Shannon Tomita, et al.
Gynecologic Oncology|February 22, 2025
Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individualsAngela C Nolin, Sage L Atkins, Evan R Myers, et al.
Gynecologic Oncology|December 10, 2016
Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancerFernanda Musa, Bhavana Pothuri, Stephanie V Blank, et al.
Gynecologic Oncology|September 18, 2014
A qualitative study of ovarian cancer survivors' perceptions of endpoints and goals of careMelissa K Frey, Sarah R Philips, Julia Jeffries, et al.
Endocrinology|September 17, 2013
Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancerSavvas C Pavlides, Kuang-Tzu Huang, Dylan A Reid, et al.
Pageof 15